UnknownNot Applicable

The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD

China741 participantsStarted 2021-09-01

Plain-language summary

Influence factors and preliminary mechanism of high incidence of thrombotic events in patients with idiopathic membranous nephropathy and diabetes kidney disease

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Primary glomerular disease patients with renal biopsy results (without hormone or immunosuppressive therapy) and patients with clinical diagnosis of diabetes kidney disease;
✓. Age 18-70;
✓. The liver function is normal.

Exclusion criteria

✕. Other secondary kidney diseases except diabetes; Acute renal injury; Chronic kidney disease stage 5;
✕. There are risk factors of hypercoagulability, such as acute infection, recent trauma, surgery or cancer, pregnancy;
✕. Anticoagulant and antiplatelet drugs were given within one week;
✕. Plasma infusion, plasma exchange or hemodialysis within one month;
✕. There is a history of thrombotic disease or hemorrhagic disease before renal puncture;
✕. Participated in other clinical studies within three months.

What they're measuring

Factors influencing the high incidence of thrombotic events in patients with membranous nephropathy and diabetic nephropathy

Timeframe: 2021-2024

Specific link between high incidence of thrombotic events in patients with membranous nephropathy and diabetic nephropathy

Timeframe: 2021-2024

Trial details

NCT IDNCT05656963

SponsorYipeng Liu

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-30

View on ClinicalTrials.gov More Glomerulonephritis, Membranous trials